:

Jialin Lu1, Yuqing Ma1, Qiuxin Li2

  • 1National Key Lab of Immunity and Inflammation and Institute of Immunology, Naval Medical University/Second Military Medical University, Shanghai, 200433, China.

Biomarker research
|August 22, 2024
PubMed
概括

化学抗原受体 (CAR) 工程化巨细胞为固体瘤提供了一个有前途的新免疫疗法. CAR巨细胞克服了CAR-T细胞治疗的局限性,提高了癌症治疗的有效性.